This opportunity is no longer accepting applications.
grant RFA-DA-23-021

Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)

This grant opportunity invites small businesses to apply for funding to develop new FDA-regulated medical products for commercialization, aimed at helping patients with opioid and stimulant use disorders. Research can focus on either new medications (small molecules and biologics) or medical devices, including software. The goal is to address the opioid and psychostimulant crisis with innovati…

This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) proposing research projects, directed towards commercialization, for the development of novel, evidence-based, FDA-regulated medical products ad…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute on Drug Abuse
Program: SBIR

Dates

Opportunity Released: March 28, 2022
Open for Submission: March 28, 2022
Submission Deadline: February 14, 2025
Application Window Closes: February 14, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.